Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 375

1.

The immediate efficacy of inhaled nitric oxide treatment in preterm infants with acute respiratory failure during neonatal transport.

Garrido F, Gonzalez-Caballero JL, Lomax R, Dady I.

Acta Paediatr. 2019 Aug 2. doi: 10.1111/apa.14958. [Epub ahead of print]

PMID:
31373038
2.

HLA Class-II Expression in Human Tumors.

Garrido F.

Adv Exp Med Biol. 2019;1151:91-95. doi: 10.1007/978-3-030-17864-2_4. Review.

PMID:
31140108
3.

HLA Class-I Expression and Cancer Immunotherapy.

Garrido F.

Adv Exp Med Biol. 2019;1151:79-90. doi: 10.1007/978-3-030-17864-2_3. Review.

PMID:
31140107
4.

MHC/HLA Class I Loss in Cancer Cells.

Garrido F.

Adv Exp Med Biol. 2019;1151:15-78. doi: 10.1007/978-3-030-17864-2_2. Review.

PMID:
31140106
5.

Introduction.

Garrido F.

Adv Exp Med Biol. 2019;1151:1-14. doi: 10.1007/978-3-030-17864-2_1. Review.

PMID:
31140105
6.

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.

Howard JF Jr, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, Ward ES, Dreier T, Ulrichts P, Verschueren K, Guglietta A, de Haard H, Leupin N, Verschuuren JJGM; Efgartigimod MG Study Group.

Neurology. 2019 Jun 4;92(23):e2661-e2673. doi: 10.1212/WNL.0000000000007600. Epub 2019 May 22.

PMID:
31118245
7.

A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer.

Flores-Martín JF, Perea F, Exposito-Ruiz M, Carretero FJ, Rodriguez T, Villamediana M, Ruiz-Cabello F, Garrido F, Cózar-Olmo JM, Aptsiauri N.

Ann Surg Oncol. 2019 Aug;26(8):2631-2639. doi: 10.1245/s10434-019-07371-2. Epub 2019 Apr 22.

PMID:
31011905
8.

Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients.

Montes P, Kerick M, Bernal M, Hernández F, Jiménez P, Garrido P, Márquez A, Jurado M, Martin J, Garrido F, Ruiz-Cabello F.

Oncotarget. 2018 Dec 11;9(97):36929-36944. doi: 10.18632/oncotarget.26405. eCollection 2018 Dec 11.

9.

Factors limiting physical activity after acute type A aortic dissection.

Schachner T, Garrido F, Bonaros N, Krapf C, Dumfarth J, Grimm M.

Wien Klin Wochenschr. 2019 Apr;131(7-8):174-179. doi: 10.1007/s00508-018-1412-2. Epub 2018 Nov 19.

10.

Historical roasting of thallium- and arsenic-bearing pyrite: Current Tl pollution in the Riotinto mine area.

López-Arce P, Garrido F, García-Guinea J, Voegelin A, Göttlicher J, Nieto JM.

Sci Total Environ. 2019 Jan 15;648:1263-1274. doi: 10.1016/j.scitotenv.2018.08.260. Epub 2018 Aug 21.

PMID:
30340272
11.

HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

Garrido MA, Rodriguez T, Zinchenko S, Maleno I, Ruiz-Cabello F, Concha Á, Olea N, Garrido F, Aptsiauri N.

Immunogenetics. 2018 Nov;70(10):647-659. doi: 10.1007/s00251-018-1074-2. Epub 2018 Aug 25.

PMID:
30145665
12.

Identification of hepatic protein-protein interaction targets for betaine homocysteine S-methyltransferase.

Garrido F, Pacheco M, Vargas-Martínez R, Velasco-García R, Jorge I, Serrano H, Portillo F, Vázquez J, Pajares MÁ.

PLoS One. 2018 Jun 20;13(6):e0199472. doi: 10.1371/journal.pone.0199472. eCollection 2018.

13.

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.

Aptsiauri N, Ruiz-Cabello F, Garrido F.

Curr Opin Immunol. 2018 Apr;51:123-132. doi: 10.1016/j.coi.2018.03.006. Epub 2018 Mar 19. Review.

PMID:
29567511
14.

Fractionation and mobility of thallium in areas impacted by mining-metallurgical activities: Identification of a water-soluble Tl(I) fraction.

Cruz-Hernández Y, Ruiz-García M, Villalobos M, Romero FM, Meza-Figueroa D, Garrido F, Hernández-Alvarez E, Pi-Puig T.

Environ Pollut. 2018 Jun;237:154-165. doi: 10.1016/j.envpol.2018.02.031. Epub 2018 Feb 23.

PMID:
29482021
15.

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.

Romero I, Garrido C, Algarra I, Chamorro V, Collado A, Garrido F, Garcia-Lora AM.

Front Immunol. 2018 Jan 29;9:102. doi: 10.3389/fimmu.2018.00102. eCollection 2018.

16.

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.

Perea F, Sánchez-Palencia A, Gómez-Morales M, Bernal M, Concha Á, García MM, González-Ramírez AR, Kerick M, Martin J, Garrido F, Ruiz-Cabello F, Aptsiauri N.

Oncotarget. 2017 Dec 19;9(3):4120-4133. doi: 10.18632/oncotarget.23469. eCollection 2018 Jan 9.

17.

Iron oxide - clay composite vectors on long-distance transport of arsenic and toxic metals in mining-affected areas.

Gomez-Gonzalez MA, Villalobos M, Marco JF, Garcia-Guinea J, Bolea E, Laborda F, Garrido F.

Chemosphere. 2018 Apr;197:759-767. doi: 10.1016/j.chemosphere.2018.01.100. Epub 2018 Feb 3.

PMID:
29407840
18.

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.

Garrido G, Rabasa A, Garrido C, Chao L, Garrido F, García-Lora ÁM, Sánchez-Ramírez B.

Front Pharmacol. 2017 Oct 6;8:595. doi: 10.3389/fphar.2017.00595. eCollection 2017.

19.

Imaging of Hydatid Disease with a Focus on Extrahepatic Involvement.

Zalaquett E, Menias C, Garrido F, Vargas M, Olivares JF, Campos D, Pinochet N, Luna A, Dahiya N, Huete Á.

Radiographics. 2017 May-Jun;37(3):901-923. doi: 10.1148/rg.2017160172. Review.

PMID:
28493801
20.

Chemistry and phase evolution during roasting of toxic thallium-bearing pyrite.

Lopez-Arce P, Garcia-Guinea J, Garrido F.

Chemosphere. 2017 Aug;181:447-460. doi: 10.1016/j.chemosphere.2017.04.109. Epub 2017 Apr 24.

PMID:
28458220
21.

Betaine homocysteine S-methyltransferase emerges as a new player of the nuclear methionine cycle.

Pérez-Miguelsanz J, Vallecillo N, Garrido F, Reytor E, Pérez-Sala D, Pajares MA.

Biochim Biophys Acta Mol Cell Res. 2017 Jul;1864(7):1165-1182. doi: 10.1016/j.bbamcr.2017.03.004. Epub 2017 Mar 10.

22.

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.

Garrido F, Perea F, Bernal M, Sánchez-Palencia A, Aptsiauri N, Ruiz-Cabello F.

Vaccines (Basel). 2017 Feb 27;5(1). pii: E7. doi: 10.3390/vaccines5010007. Review.

23.

Crystal structure of (1R,3aR,7aR)-1-{(S)-1-[(2R,5S)-5-(3-hy-droxy-pentan-3-yl)tetra-hydro-furan-2-yl]eth-yl}-7a-methyl-2,3,3a,4,5,6,7,7a-octa-hydro-1H-inden-4-one.

Martínez A, Santalla H, Garrido F, Barry AH, Gaye M, Fall Diop Y.

Acta Crystallogr E Crystallogr Commun. 2017 Jan 6;73(Pt 2):115-117. doi: 10.1107/S2056989016020648. eCollection 2017 Feb 1.

24.

Rejection versus escape: the tumor MHC dilemma.

Garrido F, Ruiz-Cabello F, Aptsiauri N.

Cancer Immunol Immunother. 2017 Feb;66(2):259-271. doi: 10.1007/s00262-016-1947-x. Epub 2016 Dec 31. Review.

PMID:
28040849
25.

The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.

Perea F, Bernal M, Sánchez-Palencia A, Carretero J, Torres C, Bayarri C, Gómez-Morales M, Garrido F, Ruiz-Cabello F.

Int J Cancer. 2017 Feb 15;140(4):888-899. doi: 10.1002/ijc.30489. Epub 2016 Nov 7.

26.

Correction: The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.

Pérez C, Pérez-Zúñiga FJ, Garrido F, Reytor E, Portillo F, Pajares MA.

PLoS One. 2016 Sep 22;11(9):e0163761. doi: 10.1371/journal.pone.0163761. eCollection 2016.

27.

The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.

Pérez C, Pérez-Zúñiga FJ, Garrido F, Reytor E, Portillo F, Pajares MA.

PLoS One. 2016 Aug 22;11(8):e0161672. doi: 10.1371/journal.pone.0161672. eCollection 2016. Erratum in: PLoS One. 2016;11(9):e0163761.

28.

Representative sampling of natural biofilms: influence of substratum type on the bacterial and fungal communities structure.

Hellal J, Michel C, Barsotti V, Laperche V, Garrido F, Joulian C.

Springerplus. 2016 Jun 21;5(1):822. doi: 10.1186/s40064-016-2448-2. eCollection 2016.

29.

Targetless T cells in cancer immunotherapy.

Thor Straten P, Garrido F.

J Immunother Cancer. 2016 Apr 19;4:23. doi: 10.1186/s40425-016-0127-z. eCollection 2016.

30.

Combining single-particle inductively coupled plasma mass spectrometry and X-ray absorption spectroscopy to evaluate the release of colloidal arsenic from environmental samples.

Gomez-Gonzalez MA, Bolea E, O'Day PA, Garcia-Guinea J, Garrido F, Laborda F.

Anal Bioanal Chem. 2016 Jul;408(19):5125-35. doi: 10.1007/s00216-016-9331-4. Epub 2016 Feb 4.

PMID:
26847190
31.

The urgent need to recover MHC class I in cancers for effective immunotherapy.

Garrido F, Aptsiauri N, Doorduijn EM, Garcia Lora AM, van Hall T.

Curr Opin Immunol. 2016 Apr;39:44-51. doi: 10.1016/j.coi.2015.12.007. Epub 2016 Jan 18. Review.

32.

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance.

Carretero FJ, Del Campo AB, Flores-Martín JF, Mendez R, García-Lopez C, Cozar JM, Adams V, Ward S, Cabrera T, Ruiz-Cabello F, Garrido F, Aptsiauri N.

Cancer Immunol Immunother. 2016 Jan;65(1):47-59. doi: 10.1007/s00262-015-1774-5. Epub 2015 Nov 26.

PMID:
26611618
33.

Colloidal mobilization of arsenic from mining-affected soils by surface runoff.

Gomez-Gonzalez MA, Voegelin A, Garcia-Guinea J, Bolea E, Laborda F, Garrido F.

Chemosphere. 2016 Feb;144:1123-31. doi: 10.1016/j.chemosphere.2015.09.090. Epub 2015 Oct 23.

PMID:
26454721
34.

Mercury mobilization and speciation linked to bacterial iron oxide and sulfate reduction: A column study to mimic reactive transfer in an anoxic aquifer.

Hellal J, Guédron S, Huguet L, Schäfer J, Laperche V, Joulian C, Lanceleur L, Burnol A, Ghestem JP, Garrido F, Battaglia-Brunet F.

J Contam Hydrol. 2015 Sep;180:56-68. doi: 10.1016/j.jconhyd.2015.08.001. Epub 2015 Aug 6.

PMID:
26275395
35.

Thallium occurrence and partitioning in soils and sediments affected by mining activities in Madrid province (Spain).

Gomez-Gonzalez MA, Garcia-Guinea J, Laborda F, Garrido F.

Sci Total Environ. 2015 Dec 1;536:268-278. doi: 10.1016/j.scitotenv.2015.07.033. Epub 2015 Jul 25.

PMID:
26218566
36.

Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach.

Blanco-Calvo M, Concha Á, Figueroa A, Garrido F, Valladares-Ayerbes M.

Int J Mol Sci. 2015 Jun 15;16(6):13610-32. doi: 10.3390/ijms160613610. Review.

37.

Arsenic speciation in the dispersible colloidal fraction of soils from a mine-impacted creek.

Serrano S, Gomez-Gonzalez MA, O'Day PA, Laborda F, Bolea E, Garrido F.

J Hazard Mater. 2015 Apr 9;286:30-40. doi: 10.1016/j.jhazmat.2014.12.025. Epub 2014 Dec 17.

PMID:
25576781
38.

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.

Garrido F, Romero I, Aptsiauri N, Garcia-Lora AM.

Int J Cancer. 2016 Jan 15;138(2):271-80. doi: 10.1002/ijc.29375. Epub 2014 Dec 13. Review.

39.

Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.

Romero I, Garrido F, Garcia-Lora AM.

Cancer Res. 2014 Dec 1;74(23):6750-7. doi: 10.1158/0008-5472.CAN-14-2406. Epub 2014 Nov 19. Review.

40.

Folic acid deficiency induces premature hearing loss through mechanisms involving cochlear oxidative stress and impairment of homocysteine metabolism.

Martínez-Vega R, Garrido F, Partearroyo T, Cediel R, Zeisel SH, Martínez-Álvarez C, Varela-Moreiras G, Varela-Nieto I, Pajares MA.

FASEB J. 2015 Feb;29(2):418-32. doi: 10.1096/fj.14-259283. Epub 2014 Nov 10.

41.

Spread and partitioning of arsenic in soils from a mine waste site in Madrid province (Spain).

Gomez-Gonzalez MA, Serrano S, Laborda F, Garrido F.

Sci Total Environ. 2014 Dec 1;500-501:23-33. doi: 10.1016/j.scitotenv.2014.08.081. Epub 2014 Sep 15.

PMID:
25217741
42.

A novel preclinical murine model of immune-mediated metastatic dormancy.

Romero I, Garrido F, Garcia-Lora AM.

Oncoimmunology. 2014 Jun 25;3:e29258. eCollection 2014.

43.

Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.

Del Campo AB, Carretero J, Muñoz JA, Zinchenko S, Ruiz-Cabello F, González-Aseguinolaza G, Garrido F, Aptsiauri N.

Cancer Gene Ther. 2014 Aug;21(8):317-32. doi: 10.1038/cgt.2014.32. Epub 2014 Jun 27.

PMID:
24971583
44.

[Nurse and nurses' aides collaboration in nursing homes].

Garnaud I, Gabriel M, Perromat J, Garrido F.

Soins Gerontol. 2014 May-Jun;(107):38-9. French. No abstract available.

PMID:
24908848
45.

Multi-bioindicators to assess soil microbial activity in the context of an artificial groundwater recharge with treated wastewater: a large-scale pilot experiment.

Michel C, Joulian C, Ollivier P, Nyteij A, Cote R, Surdyk N, Hellal J, Casanova J, Besnard K, Rampnoux N, Garrido F.

J Microbiol Biotechnol. 2014 Jun 28;24(6):843-53.

46.

T lymphocytes restrain spontaneous metastases in permanent dormancy.

Romero I, Garrido C, Algarra I, Collado A, Garrido F, Garcia-Lora AM.

Cancer Res. 2014 Apr 1;74(7):1958-68. doi: 10.1158/0008-5472.CAN-13-2084. Epub 2014 Feb 14.

47.

Reliability and validity of the Spanish version of the Pittsburgh Sleep Quality Index (PSQI) in patients with fibromyalgia.

Hita-Contreras F, Martínez-López E, Latorre-Román PA, Garrido F, Santos MA, Martínez-Amat A.

Rheumatol Int. 2014 Jul;34(7):929-36. doi: 10.1007/s00296-014-2960-z. Epub 2014 Feb 8.

PMID:
24509897
48.

Involvement of HLA class I molecules in the immune escape of urologic tumors.

Carretero R, Gil-Julio H, Vázquez-Alonso F, Garrido F, Castiñeiras J, Cózar JM.

Actas Urol Esp. 2014 Apr;38(3):192-9. doi: 10.1016/j.acuro.2013.06.006. Epub 2013 Dec 7. Review. English, Spanish.

PMID:
24315763
49.

Acute liver injury induces nucleocytoplasmic redistribution of hepatic methionine metabolism enzymes.

Delgado M, Garrido F, Pérez-Miguelsanz J, Pacheco M, Partearroyo T, Pérez-Sala D, Pajares MA.

Antioxid Redox Signal. 2014 Jun 1;20(16):2541-54. doi: 10.1089/ars.2013.5342. Epub 2014 Jan 3.

50.

Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.

Garrido G, Rabasa A, Garrido C, López A, Chao L, García-Lora AM, Garrido F, Fernández LE, Sánchez B.

Oncogene. 2014 Jun 12;33(24):3129-39. doi: 10.1038/onc.2013.288. Epub 2013 Aug 26.

PMID:
23975426

Supplemental Content

Loading ...
Support Center